Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Stephen Fogarasi
Introduction
Stephen Fogarasi is an accomplished inventor based in Pawling, NY (US). He has made significant contributions to the field of medical technology, particularly in the area of predictive modeling for prostate cancer. His innovative approach combines clinical, molecular, and morphometric information to enhance the accuracy of medical predictions.
Latest Patents
Stephen Fogarasi holds a patent for a method and system designed to determine the risk of occurrence of prostate cancer. This patent utilizes clinical information, molecular data, and computer-generated morphometric information to create a predictive model. The model is particularly focused on predicting the risk of prostate cancer progression in patients. Key features of the model include preoperative PSA levels, dominant Gleason Grade, Gleason Score, and various morphometric measurements derived from tissue analysis.
Career Highlights
Throughout his career, Stephen has worked with notable organizations, including the Champalimaud Foundation. His work has been instrumental in advancing the understanding of prostate cancer and improving patient outcomes through innovative predictive models. His dedication to research and development in this field has established him as a respected figure among his peers.
Collaborations
Stephen has collaborated with professionals such as Michael Donovan and Faisal Khan. These partnerships have further enriched his research and contributed to the development of his patented technologies.
Conclusion
Stephen Fogarasi's innovative work in the field of prostate cancer prediction exemplifies the impact of combining clinical and technological advancements. His contributions continue to influence medical research and patient care.